FI68222C - Foerfarande foer 0-metylering av hydroxiaporfiner - Google Patents

Foerfarande foer 0-metylering av hydroxiaporfiner Download PDF

Info

Publication number
FI68222C
FI68222C FI783951A FI783951A FI68222C FI 68222 C FI68222 C FI 68222C FI 783951 A FI783951 A FI 783951A FI 783951 A FI783951 A FI 783951A FI 68222 C FI68222 C FI 68222C
Authority
FI
Finland
Prior art keywords
methylation
hydroxy
och3
reaction
methylated
Prior art date
Application number
FI783951A
Other languages
English (en)
Finnish (fi)
Other versions
FI68222B (fi
FI783951A (fi
Inventor
Johannes Hartenstein
Gerhard Satzinger
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI783951A publication Critical patent/FI783951A/fi
Application granted granted Critical
Publication of FI68222B publication Critical patent/FI68222B/fi
Publication of FI68222C publication Critical patent/FI68222C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Claims (9)

1 H 'ry'" r7 R6 där minst en av symbolerna - R„ är en hydroxylgrupp och de andra symbolerna är väteatomer eller substituente vilka är inerta under reaktionsbetingelserna, som används, och Rg är en lägre al-kylgrupp, O-metyleras i ett inert lösningsmedel med en förening med formeln CH3 _ j1—- CH3 · X ® II ^ CH3 där X® är en hydroxylgrupp eller en lägre alkoxigrupp, varefter reaktionsprodukten isoleras och, om sä önskas, omvandlas tili ett farmakologiskt godtagbart sait.
1. Förfarande för O-metylering av hydroxiaporfiner, k ä n-netecknat därav, att de fenoliska hydroxylgrupperna i en förening raed formeln fl H\^H H H
2. Förfarande enligt patentkravet l,kännetecknat därav, att alkyleringsmedlet, som används, är fenvltrimetylammonium-metylat eller fenyltrimetylammoniumetylat.
3. Förfarande enligt patentkravet 1 eller 2, känneteck--n a t därav, att O-metyleringen utförs vid en temperatur av 100 - 15 0°C.
4. Förfarande enligt patentkravet 3,kännetecknat därav, att O-metyleringen utförs vid en temperatur av 110 - 135°C.
5. Förfarande enligt nägot av fcregäende patentkrav, k ä n-netecknat därav, att lösningsmedlet, som används, är en blandning av ett kolväte och ett polärt lösningsmedel. li
FI783951A 1977-12-22 1978-12-21 Foerfarande foer 0-metylering av hydroxiaporfiner FI68222C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2757335A DE2757335C3 (de) 1977-12-22 1977-12-22 Verfahren zur O-Methylierung von Hydroxyaporphinen
DE2757335 1977-12-22

Publications (3)

Publication Number Publication Date
FI783951A FI783951A (fi) 1979-06-23
FI68222B FI68222B (fi) 1985-04-30
FI68222C true FI68222C (fi) 1985-08-12

Family

ID=6026924

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783951A FI68222C (fi) 1977-12-22 1978-12-21 Foerfarande foer 0-metylering av hydroxiaporfiner

Country Status (14)

Country Link
US (1) US4309542A (sv)
JP (1) JPS54119474A (sv)
AT (1) AT362535B (sv)
BE (1) BE872843A (sv)
CH (1) CH645629A5 (sv)
CS (1) CS238601B2 (sv)
DD (1) DD141830A5 (sv)
DE (1) DE2757335C3 (sv)
FI (1) FI68222C (sv)
FR (1) FR2430942A1 (sv)
GB (1) GB2010841B (sv)
HU (1) HU177060B (sv)
NL (1) NL7812394A (sv)
SU (1) SU925249A3 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118521A1 (de) * 1981-05-09 1982-12-02 Gödecke AG, 1000 Berlin Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien
US4795759A (en) * 1985-07-27 1989-01-03 Sandoz Ltd. Use of dibenz(CD,F)indoles
US6210680B1 (en) 1999-06-11 2001-04-03 Univera Pharmaceuticals, Inc. Method for the prevention and treatment of chronic venous insufficiency
TWI225397B (en) * 2000-05-04 2004-12-21 Nat Science Council Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of the same
RU2350326C2 (ru) * 2000-08-23 2009-03-27 Лотус Фармасьютикал Ко., Лтд Применение талипорфина или его производных в лечении заболеваний сердца, а также их получение
AU2003242227A1 (en) * 2003-06-19 2005-01-04 Lotus Pharmaceutical Co., Ltd. Aporphine and oxoaporphine and the medical use thereof
CN1884265A (zh) * 2005-06-20 2006-12-27 美时化学制药股份有限公司 治疗糖尿病的阿朴芬及次阿朴芬化合物
WO2007134485A1 (en) * 2006-05-22 2007-11-29 Lotus Pharmaceutical Co., Ltd. Aporphine and oxoaporphine compounds and pharmaceutical use thereof
TWI531369B (zh) * 2014-05-30 2016-05-01 資元堂生物科技股份有限公司 阿朴啡生物鹼衍生物用於製備促進ａｍｐｋ活性的藥物之用途
CN111196801B (zh) * 2020-01-14 2022-10-14 中国药科大学 阿朴菲类生物碱衍生物及其制备方法与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1100998A (en) * 1912-05-06 1914-06-23 Firm Of Mckesson & Robbins Process of manufacuring alkyl-ethers of morphin.
GB1364318A (en) * 1971-03-15 1974-08-21 Bellon Labor Sa Roger Laurotetanine derivatives
DE2337507A1 (de) * 1973-07-24 1975-02-13 Research Corp Verfahren zur herstellung von aporphinen ueber neue zwischenprodukte
DE2625116C2 (de) * 1976-06-04 1984-01-26 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von 4-Hydroxy-aporphin-Derivaten

Also Published As

Publication number Publication date
GB2010841B (en) 1982-08-18
DE2757335B2 (de) 1981-05-27
HU177060B (hu) 1981-06-28
GB2010841A (en) 1979-07-04
FI68222B (fi) 1985-04-30
FR2430942A1 (fr) 1980-02-08
SU925249A3 (ru) 1982-04-30
FR2430942B1 (sv) 1985-02-22
DD141830A5 (de) 1980-05-21
CS238601B2 (en) 1985-12-16
AT362535B (de) 1981-05-25
DE2757335C3 (de) 1982-03-25
DE2757335A1 (de) 1979-06-28
US4309542A (en) 1982-01-05
BE872843A (fr) 1979-04-17
CH645629A5 (de) 1984-10-15
FI783951A (fi) 1979-06-23
JPS54119474A (en) 1979-09-17
ATA913578A (de) 1980-10-15
NL7812394A (nl) 1979-06-26

Similar Documents

Publication Publication Date Title
FI68222C (fi) Foerfarande foer 0-metylering av hydroxiaporfiner
Kupchan et al. Photochemical synthesis of aporphines
HU185133B (en) Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives
FR2485537A2 (fr) Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
Moody et al. Vinyl azides in heterocyclic synthesis. Part 10. Synthesis of the isoindolobenzazepine alkaloid lennoxamine
KR20120093105A (ko) 이바브라딘 및 이의 약제학적으로 허용되는 산과의 부가염을 합성하는 방법
JP2011513197A (ja) ポリヒドロキシスチルベン化合物の合成方法
US3726924A (en) Method for the preparation of tris (dimethylamino) methane
JP2009173672A (ja) 化合物の求核置換反応における使用
KR101625128B1 (ko) 3,4-디메톡시바이사이클로[4.2.0]옥타-1,3,5-트리엔-7-카보니트릴의 합성 방법, 및 이바브라딘 및 이의 약제학적으로 허용되는 산과의 부가염의 합성에서의 적용
KR101637177B1 (ko) 8-히드록시클로미프라민 또는 이의 약학적으로 허용가능한 염의 제조방법
FR2997696A1 (fr) Nouveau procede de synthese du (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FI79100B (fi) Isokinolinderivat och foerfarande foer framstaellning daerav.
US3453283A (en) Novel 6-substituted-1-(piperidyl-alkyl)-1,2,3,4-tetrahydronaphthalenes
ITOH et al. The Syntheses and β-Adrenoceptor Activities of N-Substituted 2-Amino-5, 6-dihydroxy-1, 2, 3, 4-tetrahydro-1-naphthalenols
Gao et al. Regioselective assembly of 3, 4-dihydroisoquinoline derivatives
Heaney et al. The synthesis of 2-arylmethyltetrahydroisoquinolines from bis (aminol) ethers involving two iminium salt intermediates
AU2013257530A1 (en) New process for the Synthesis of 3-(2-Bromo-4,5-dimethoxyphenyl)propanenitrile, and Application in the Synthesis of Ivabradine and Addition Salts Thereof With a Pharmaceutically Acceptable Acid
Gan et al. An improved synthesis of substituted indan-1-carboxylic acid
KR100932071B1 (ko) 벤잘아세토페논 유도체의 제조방법
US4301290A (en) Organic compounds
Ahmad et al. Aryne Formation from 2-Bromolaudanosine. Fate of the 5, 6, 12, 12a-Tetrahydrodibenzo [b, g] indolizinium Ion and an Alternative Synthesis of Glaucine
KR101620158B1 (ko) 1-알킬-2-페닐-4-퀴놀론의 제조방법
US4376860A (en) Pyridyl ketone
Hutchison et al. Central nervous system active compounds. IV. Synthesis of 3-aminobenzylphthalides

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: WARNER-LAMBERT COMPANY